Events | News | Resources | Partners | Contact Us | About Us
rhPDGF-BB | β-TCP | Mechanism of Action | Evidence of Regeneration | Clinical Performance
Directions for Use | FAQs | Home
The matrix component of GEM 21S® is a highly porous, synthetic beta-tricalcium phosphate (β-TCP) material intended to fill the bony void and provide an osteoconductive matrix for cellular migration and proliferation and subsequent matrix deposition. This material also has a long history of safe and effective use in a variety of medical applications.
Biocompatibility

Because β-TCP is a synthetic material, it avoids patient concerns surrounding perceived risks associated with biological materials from animal or human sources.

Scanning Electron Microscopy (SEM) of β-TCP

The β-TCP used in GEM 21S® is specifically designed for optimal bone in-growth, with a pore diameter ranging from 1 to 500 microns. The particle size ranges from 0.25 to 1.0 mm. Both the pore and particle size have been optimized to provide an osteoconductive matrix for natural bone formation. Because of its microstructure and bio-resorbability, bone and other resident tissues replace it as they grow into the space occupied by the scaffold.

When selecting the appropriate osteoconductive matrix to combine with a growth factor, the release kinetics must be evaluated. β-TCP has been found to release PDGF within minutes. Release occurs as an initial burst followed by a slow and sustained release over a number of days. This is consistent with PDGF's role in initiating the wound healing cascade.

Important Safety Information.

View the Package Insert:
United States
Canada - English
Canada - French

To view a presentation about
GEM 21S®, click here.

SEM of β-TCP at Various Magnifications
SEM's of β-TCP courtesy of Orthovita, Inc.